Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Short Interest Update

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) saw a large decrease in short interest in November. As of November 15th, there was short interest totalling 114,800 shares, a decrease of 32.9% from the October 31st total of 171,200 shares. Based on an average daily trading volume, of 38,600 shares, the days-to-cover ratio is currently 3.0 days. Currently, 0.8% of the shares of the stock are sold short.

Insider Activity

In other news, major shareholder Fosun Pharmaceutical Shanghai sold 3,000 shares of the stock in a transaction on Thursday, October 10th. The shares were sold at an average price of $13.39, for a total value of $40,170.00. Following the completion of the transaction, the insider now owns 69,347 shares in the company, valued at approximately $928,556.33. This represents a 4.15 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In the last 90 days, insiders sold 7,499 shares of company stock worth $99,802. 4.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Nature’s Sunshine Products

A number of hedge funds have recently added to or reduced their stakes in NATR. Franklin Resources Inc. boosted its stake in shares of Nature’s Sunshine Products by 4.3% in the 3rd quarter. Franklin Resources Inc. now owns 20,744 shares of the company’s stock valued at $270,000 after purchasing an additional 856 shares during the last quarter. Jacobs Levy Equity Management Inc. boosted its stake in shares of Nature’s Sunshine Products by 1.6% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 58,507 shares of the company’s stock valued at $1,215,000 after purchasing an additional 927 shares during the last quarter. Lazard Asset Management LLC boosted its stake in shares of Nature’s Sunshine Products by 16.5% in the 1st quarter. Lazard Asset Management LLC now owns 7,040 shares of the company’s stock valued at $146,000 after purchasing an additional 998 shares during the last quarter. Gladius Capital Management LP boosted its stake in shares of Nature’s Sunshine Products by 23.9% in the 2nd quarter. Gladius Capital Management LP now owns 6,862 shares of the company’s stock valued at $103,000 after purchasing an additional 1,325 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in shares of Nature’s Sunshine Products by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 659,686 shares of the company’s stock valued at $13,702,000 after acquiring an additional 3,792 shares during the period. Institutional investors own 79.40% of the company’s stock.

Nature’s Sunshine Products Stock Up 0.6 %

NASDAQ:NATR traded up $0.09 during mid-day trading on Friday, reaching $16.24. 20,167 shares of the company were exchanged, compared to its average volume of 52,680. Nature’s Sunshine Products has a 12 month low of $10.81 and a 12 month high of $21.72. The company has a fifty day moving average of $14.10 and a 200 day moving average of $14.51. The stock has a market cap of $300.12 million, a PE ratio of 18.35 and a beta of 0.87.

Analyst Ratings Changes

NATR has been the topic of several analyst reports. StockNews.com raised shares of Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a report on Tuesday, September 10th. Canaccord Genuity Group initiated coverage on shares of Nature’s Sunshine Products in a report on Friday, September 13th. They issued a “buy” rating and a $18.00 target price on the stock. DA Davidson lowered their target price on shares of Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating on the stock in a report on Monday, August 12th. Finally, Canaccord Genuity Group began coverage on shares of Nature’s Sunshine Products in a report on Friday, September 13th. They issued a “buy” rating and a $18.00 target price on the stock.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.